OpenAlex
PricingAboutJobs
Log inGet started
Work

Improving the efficacy and safety of antipsychotic therapy with genetically determined efflux inhibition (case report)

HTML

Year: 2025
Type: article
Study design: Case Report
Source: Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery)
DOI: 10.33920/med-01-2505-03
Authors: A. V. Kidyaeva, A. S. Shumilova, J. A. Makarov, M. M. Petrova, N. A. Shnayder, R. F. Nasyrova
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: schizophrenia, paranoid schizophrenia, antipsychotic adverse effects, QT prolongation, torsades de pointes, pharmacogenetics, MDR1 gene, P-glycoprotein, drug efflux inhibition, blood-brain barrier, pharmacogenetic testing, atypical antipsychotics, third-generation antipsychotics
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4411123783
FWCI:
Cites: 20
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms